Apic Bio Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Apic bio inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Apic Bio Inc Today - Breaking & Trending Today

Apic Bio Announces FDA Clearance of IND Application for Lead Gene Therapy Candidate APB-102 for the Treatment of SOD1 ALS


Press release content from Business Wire. The AP news staff was not involved in its creation.
Apic Bio Announces FDA Clearance of IND Application for Lead Gene Therapy Candidate APB-102 for the Treatment of SOD1 ALS
April 21, 2021 GMT
CAMBRIDGE, Mass. (BUSINESS WIRE) Apr 21, 2021
Apic Bio, Inc., an innovative gene therapy company developing novel treatment options for patients with rare genetic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for APB-102, the Company’s lead gene therapy candidate designed to treat SOD1 amyotrophic lateral sclerosis (ALS) - a common cause of familial ALS. ....

United States , United Kingdom , University Of Massachusetts Medical School , North Lanarkshire , Jorge Quiroz , David Rosen , Joseph Rayne , John Reilly , Robert Brown , Apic Bio , Scientific Co , Apic Bio Inc , Investment Fund , Drug Administration , Investigational New Drug , Chief Executive Officer , Chief Medical Officer , Massachusetts Medical School , Scientific Co Founder , Morningside Ventures , Business Wire , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பல்கலைக்கழகம் ஆஃப் மாசசூசெட்ஸ் மருத்துவ பள்ளி , வடக்கு லானர்க்ஷயர் , ஜார்ஜ் குய்ரோஸ் ,